1. Vyles D, Chiu A, Simpson P, Nimmer M, Adams J, Brousseau DC. Parentreported penicillin allergy symptoms in the pediatric emergency department. Acad Pediatr. 2017;17(3):251–255
2. Chiriac AM; Demoly P. . . Drug Allergy. In: Leung DY, Sampson HA, Bonilla FA, Akdis CA, Szefler SJ, eds. Pediatric Allergy: Principles and Practice, 3rd ed. . . . Edinburgh: Elsevier; 2016:498–504
3. MacFadden DR, LaDelfa A, Leen J, et al. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study. Clin Infect Dis. 2016;63(7):904–910
4. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133(3):790–796
5. Vyles D, Adams J, Chiu A, Simpson P, Nimmer M, Brousseau DC. Allergy testing in children with low-risk penicillin allergy symptoms. Pediatrics.2017;140(2):e20170471
6. Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: from self-reporting toconfirmed diagnosis. Clin Exp Allergy.2008;38(1):191–198
7. Vezir E, Erkocoglu M, Civelek E, et al. The evaluation of drug provocationtests in pediatric allergy clinic: a single center experience. Allergy Asthma Proc. 2014;35(2):156–162
8. Picard M, Paradis L, Nguyen M, Bégin P, Paradis J, Des Roches A. Outpatient penicillin use after negative skin testing and drug challenge in a pediatric population. Allergy Asthma
Proc. 2012;33(2):160–164
9. Gerace KS, Phillips E. Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract. 2015;3(5):815–816
10. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported betalactam allergy. Arch Fam Med. 2000;9(8):722–726
11. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology,and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010;304(19):2161–2169
12. Phillips E, Mallal S. Drug hypersensitivity in HIV. Curr Opin Allergy Clin Immunol. 2007;7(4):324–330
13. Caimmi S, Sanfiorenzo C, Caimmi D, Bousquet PJ, Chiron R, Demoly P. Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics. Clin Transl Allergy. 2012;2(1):10
14. Petroni DH, Aitken ML, Ham E, et al.Approach to the evaluation of adverseantibiotic reactions in patients with cystic fibrosis. Ann Allergy Asthma Immunol. 2016;117(4):378–381
15. Pichichero ME. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics. 2005;115(4):1048–1057
16. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr. 2008;152(3):416–421
17. Star K, Norén GN, Nordin K, Edwards IR. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase. Drug Saf. 2011;34(5):415–428
18. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics. 2006;118(2):555–562
19. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5(4):309–316
20. Chan DS, Callahan CW, Moreno C. Multidisciplinary education and management program for children with asthma. Am J Health Syst Pharm. 2001;58(15):1413–1417
21. Kerr JR. Penicillin allergy: a study of incidence as reported by patients. Br J Clin Pract. 1994;48(1):5–7
22. Smyth RM, Gargon E, Kirkham J, et al. Adverse drug reactions in children—a systematic review. PLoS One. 2012;7(3):e24061
23. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993;270(20):2456–2463
24. Macy E, Poon K-Y T. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122(8):778.e1–778.e7
25. Vezir E, Erkocoglu M, Civelek E, et al. The evaluation of drug provocationtests in pediatric allergy clinic: a single center experience. Allergy Asthma Proc. 2014;35(2):156–162
26. Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to beta-lactam antibioticsin children: results of a 20-yearstudy based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22(4):411–418
27. Iglesias-Souto J, González R, Poza P, Sanchez-Machín I, Matheu V. Evaluating the usefulness of retesting for betalactam allergy in children. Pediatr Infect Dis J. 2012;31(10):1091–1093
28. Mattheij M, de Vries E. A suspicion of antibiotic allergy in children is often incorrect. J Allergy Clin Immunol. 2012;129(2):583; author reply 583–584
29. Seitz CS, Bröcker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol. 2011;22(4):405–410
30. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med. 2004;140(12):1001–1006
31. Caubet JC, Kaiser L, Lemaître B, FellayB, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol. 2011;127(1):218–222
32. Caubet JC, Eigenmann PA. Managing possible antibiotic allergy in children. Curr Opin Infect Dis.2012;25(3):279–285
33. Erkoçoglu M, Kaya A, Civelek E, et al. Prevalence of confirmed immediatetype drug hypersensitivity reactions among school children. Pediatr Allergy Immunol. 2013;24(2):160–167
34. Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy is not necessarily forever. JAMA. 2017;318(1):82–83
35. Atanaskovic-Markovic M, Gaeta F, Medjo B, et al. Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up. Pediatr Allergy Immunol. 2016;27(5):533–538
36. Arikoglu T, Aslan G, Batmaz SB, Eskandari G, Helvaci I, Kuyucu S. Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests. Int J Clin Pharm. 2015;37(4):583–591
37. Chambel M, Martins P, Silva I, PalmaCarlos S, Romeira AM, Leiria Pinto P. Drug provocation tests to betalactam antibiotics: experience in a paediatric setting. Allergol Immunopathol (Madr). 2010;38(6):300–306
38. Romano A, Caubet J-C. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014;2(1):3–12
39. Ibia EO, Schwartz RH, Wiedermann BL. Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol. 2000;136(7):849–854
40. Solensky R. Allergy to β-lactam antibiotics. J Allergy Clin Immunol. 2012;130(6):1442–1442.e5
41. Pawankar R, Canonica GW, Holgate ST, Lockey RF. WAO White Book on Allergy 2011-2012 Executive Summary. Milwaukee, WI: World Allergy Association; 2011
42. Torres MJ, Ariza A, Mayorga C, et al. Clavulanic acid can be thecomponent in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol. 2010;125(2):502–505.e2
43. Zambonino MA, Corzo JL, Muñoz C, et al. Diagnostic evaluation ofhypersensitivity reactions to betalactamantibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25(1):80–87
44. Gomes ER, Brockow K, Kuyucu S, et al; ENDA/EAACI Drug Allergy Interest Group. Drug hypersensitivity in children: report from the pediatric task force of the EAACIDrug Allergy Interest Group. Allergy. 2016;71(2):149–161
45. Barni S, Butti D, Mori F, et al. Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides. J Investig Allergol Clin Immunol. 2015;25(2):128–132
46. Mori F, Pecorari L, Pantano S, et al. Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol.2014;27(1):121–126
47. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma, and Immunology; Joint Council of Allergy, Asthma, and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–273
48. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7): 588–597
49. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl JMed. 1994;331(19):1272–1285
50. Gómez-Traseira C, Boyano-Martínez T, Escosa-García L, Pedrosa M, Martín Muñoz F, Quirce S. Trimethoprim sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl. Pediatr Allergy Immunol.2015;26(3):287–289
51. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684–700
52. Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA Jr, Phillips EJ. Pharmacogenomics of off-target adverse drug reactions. Br J Clin Pharmacol. 2017;83(9):1896–1911
53. White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cellmediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015;136(2):219–234; quiz 235
54. Phillips EJ. Classifying ADRs—does dose matter? Br J Clin Pharmacol. 2016;81(1):10–12
55. Dioun AF. Management of multipledrug allergies in children. Curr AllergyAsthma Rep. 2012;12(1):79–84
56. Caubet JC, Eigenmann PA. Diagnostic issues in pediatric drug allergy. Curr Opin Allergy Clin Immunol. 2012;12(4):341–347
57. McNeil BD, Pundir P, Meeker S, et al. Identification of a mast-cell specific receptor crucial for pseudoallergic drug reactions. Nature. 2015;519(7542):237–241
58. Azimi E, Reddy VB, Lerner EA. Brief communication: MRGPRX2, atopic dermatitis and red man syndrome. Itch (Phila). 2017;2(1):e5
59. Gell P, Coombs R, Lachmann P. Classification of allergic reactions for clinical hypersensitivity disease. In: Gell PGH, Coombs RPA, eds. Clinical Aspects of Immunology. Oxford, United Kingdom: Blackwell Scientific Publications; 1968:575–579
60. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med. 2003;139(8):683–693
61. Pichler WJ, Beeler A, Keller M, et al. Pharmacological interaction of drugs with immune receptors: the p-I concept. Allergol Int. 2006;55(1):17–25
62. Aung AK, Haas DW, Hulgan T, Phillips EJ. Pharmacogenomics of antimicrobial agents. Pharmacogenomics. 2014;15(15):1903–1930
63. Trubiano J, Phillips E. Antimicrobial stewardship’s new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’. Curr Opin Infect Dis.2013;26(6):526–537
64. Muraro A, Lemanske RF Jr, Castells M, et al. Precision medicine in allergic disease-food allergy, drug allergy, and anaphylaxis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology. Allergy.2017;72(7):1006–1021
65. Blanca-Lopez N, Perez-Alzate D, Ruano F, et al. Selective immediate responders toamoxicillin and clavulanic acid toleratepenicillin derivative administration after confirming the diagnosis. Allergy. 2015;70(8):1013–1019
66. Esposito S, Castellazzi L, Tagliabue C, Principi N. Allergy to antibiotics in children: an overestimated problem. Int J Antimicrob Agents. 2016;48(4):361–366
67. Blanca-López N, Ariza A, Doña I, et al. Hypersensitivity reactions tofluoroquinolones: analysis of thefactors involved. Clin Exp Allergy. 2013;43(5):560–567
68. Venturini Díaz M, Lobera Labairu T, del Pozo Gil MD, Blasco Sarramián A, González Mahave I. In vivo diagnostic tests in adverse reactions to quinolones. J Investig Allergol ClinImmunol. 2007;17(6):393–398
69. Pichichero ME, Zagursky R. Penicillin and cephalosporin allergy. AnnAllergy Asthma Immunol. 2014;112(5):404–412
70. Romano A, Gaeta F, Valluzzi RL, et al. IgE-mediated hypersensitivityto cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol.2015;136(3):685–691.e3
71. Romano A, Gaeta F, Arribas Poves MF, Valluzzi RL. Cross-reactivity amongbeta-lactams. Curr Allergy Asthma Rep.2016;16(3):24
72. Audicana M, Bernaola G, Urrutia I, et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin and evaluation of cross reactivity with cephalosporin. Allergy. 1994;49(2):108–113
73. Novalbos A, Sastre J, Cuesta J, et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy.2001;31(3):438–443
74. Antunez C, Blanca-Lopez N, Torres MJ, et al. Immediate allergic reactions tocephalosporins: evaluation of crossreactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol. 2006;117(2):404–410
75. Romano A, Gaeta F, Valluzzi RL, Caruso C, Rumi G, Bousquet PJ. IgE-mediatedhypersensitivity to cephalosporins:cross-reactivity and tolerabilityof penicillins, monobactams, and
carbapenems. J Allergy Clin Immunol. 2010;126(5):994–999
76. Mill C, Primeau MN, Medoff E, et al. Assessing the diagnostic properties ofa graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr. 2016;170(6):e160033
77. Kuhlen JL Jr, Camargo CA Jr, Balekian DS, et al. Antibiotics are the most commonlyidentified cause of perioperativehypersensitivity reactions. J Allergy Clin Immunol Pract. 2016;4(4):697–704
78. Gonzalez-Estrada A, Silvers SK, Klein A, Zell K, Wang XF, Lang DM.Epidemiology of anaphylaxis at atertiary care center: a report of 730 cases. Ann Allergy Asthma Immunol. 2017;118(1):80–85
79. Gonzalez-Estrada A, Pien LC, Zell K, Wang XF, Lang DM. Antibiotics arean important identifiable cause ofperioperative anaphylaxis in the United States. J Allergy Clin Immunol Pract. 2015;3(1):101–105.e1
80. Hierro Santurino B, Mateos Conde J, Cabero Morán MT, Mirón Canelo JA, Armentia Medina A. A predictive model for the diagnosis of allergic drug reactions according to the medical history. J Allergy Clin Immunol Pract. 2016;4(2):292–300.e3
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.